DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Dore GJ, Conway B, Luo Y. et al.
Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials.
J Hepatol 2016;
64: 19-28
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.